TrialDrug design, development and therapy2014

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.

Namyi Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.